Dashboard
Manage Tickers

TOVXTheriva Biologics, Inc.

NYSE therivabio.com


$ 0.34 $ -0.03 (-8.56 %)    

Thursday, 23-May-2024 15:59:15 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -2.05 (-0.45 %)
DIA $ 398.57 $ -6.00 (-1.51 %)
SPY $ 530.36 $ -3.87 (-0.73 %)
TLT $ 91.26 $ -0.59 (-0.64 %)
GLD $ 225.37 $ -4.39 (-1.99 %)
$ 0.331
$ 0.49
$ 0.00 x 0
$ 0.00 x 0
$ 0.32 - $ 0.58
$ 0.20 - $ 1.20
20,679,619
na
5.68M
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-16-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 03-04-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-20-2020 12-31-2019 10-K
19 11-04-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 11-01-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-02-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-10-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 03-16-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

theriva-biologics-receives-fda-fast-track-designation-for-vcn-01-in-combination-with-gemcitabine-and-nab-paclitaxel-to-improve-survival-in-metastatic-pancreatic-adenocarcinoma
Theriva Biologics Receives FDA Fast Track ...
05/23/2024 12:20:33

theriva-biologics-shares-are-trading-higher-after-the-fda-granted-fast-track-designation-to-vcn-01
Theriva Biologics shares are trading highe...
05/23/2024 12:17:29

theriva-biologics-reports-183m-in-cash-for-q1-2024-which-is-expected-to-provide-runway-into-the-first-quarter-of-2025
Theriva Biologics Reports $18.3M In Cash F...
05/07/2024 11:15:21

theriva-biologics-q1-2024-gaap-eps-030-misses-027-estimate
Theriva Biologics Q1 2024 GAAP EPS $(0.30)...
05/07/2024 11:14:20

theriva-biologics-files-mixed-securities-shelf
Theriva Biologics Files Mixed-Securities S...
05/02/2024 21:21:18

theriva-biologics-to-discuss-the-trial-design-for-virage---a-phase-2b-clinical-study-of-systemically-administered-vcn-01-in-combination-with-chemotherapy-in-pancreatic-ductal-adenocarcinoma-at-the-2024-asco-annual-meeting
Theriva Biologics To Discuss The Trial Des...
04/25/2024 12:34:38

Theriva™ Biologics (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and relat...

theriva-biologics-disclosed-positive-topline-data-from-investigator-sponsored-phase-1-trial-of-intravitreal-vcn-01-in-pediatric-patients-with-refractory-retinoblastoma
Theriva Biologics Disclosed Positive Topli...
04/23/2024 12:40:08

why-hibbett-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Hibbett Shares Are Trading Higher By 1...
04/23/2024 12:00:50

theriva-biologics-to-present-preclinical-data-for-potential-synergy-of-vcn-01-and-first-line-pancreatic-cancer-chemotherapy-regimens-at-american-society-for-cell-and-gene-therapy-27th-annual-meeting
Theriva Biologics To Present Preclinical D...
04/22/2024 20:37:21

– Lead product candidate, VCN-01 in combination with liposomal irinotecan demonstrated enhanced anti-tumor effects in a human p...

theriva-biologics-fy-eps-114-beats-128-estimate-as-of-december-31-2023-theriva-biologics-reports-232m-in-cash-which-is-expected-to-provide-runway-into-the-first-quarter-of-2025
Theriva Biologics FY EPS $(1.14) Beats $(1...
03/25/2024 11:32:39

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(1.14) per share which beat the analyst consensus estimate of $(1.2...

earnings-scheduled-for-march-25-2024
Earnings Scheduled For March 25, 2024
03/25/2024 09:33:46

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on re...

preview-theriva-biologicss-earnings
Preview: Theriva Biologics's Earnings
03/22/2024 14:01:40

theriva-biologics-granted-eu-patent-3292142-for-oncolytic-adenoviruses-with-mutations-in-immunodominant-adenovirus-epitopes-and-their-use-in-cancer-treatment
Theriva Biologics Granted EU Patent #32921...
03/20/2024 20:01:09

https://data.epo.org/publication-server/pdf-document?pn=3292142&ki=B1&cc=EP

theriva-biologics-announces-positive-recommendation-from-the-independent-data-monitoring-committee-of-virage-the-phase-2b-clinical-trial-of-vcn-01-in-combination-with-chemotherapy-for-metastatic-pancreatic-ductal-adenocarcinoma
Theriva Biologics Announces Positive Recom...
02/07/2024 13:02:56

Theriva™ Biologics (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and relat...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/25/2023 17:30:49

theriva-biologics-q3-eps-019-beats-038-estimate-312m-in-cash-which-is-expected-to-provide-runway-into-the-first-quarter-of-2025
Theriva Biologics Q3 EPS $(0.19) Beats $(0...
11/13/2023 13:05:17

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.3...

earnings-scheduled-for-november-13-2023
Earnings Scheduled For November 13, 2023
11/13/2023 11:40:53

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

earnings-outlook-for-theriva-biologics
Earnings Outlook For Theriva Biologics
11/10/2023 18:01:46

theriva-biologics-and-sant-joan-de-du-barcelona-childrens-hospital-advance-strategic-collaboration-to-explore-combination-of-vcn-01-with-topoisomerase-inhibitors-to-treat-cancer
Theriva Biologics And Sant Joan de Déu-Bar...
11/02/2023 12:06:33

theriva-biologics-announced-new-clinical-data-from-phase-1-investigator-sponsored-study-with-institut-catala-doncologia-evaluating-vcn-01-in-combination-with-durvalumab
Theriva Biologics Announced New Clinical D...
10/23/2023 11:12:18

These data were presented at the European Society for Medical Oncology (ESMO) Congress, held both virtually and in Madrid, Spai...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION